Papers associated with gria1

???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 ???pagination.result.next???

Sort Newest To Oldest

Sort Oldest To Newest

	Subtype-specific effects of lithium on glutamate receptor function., Karkanias NB, Papke RL., J Neurophysiol. April 1, 1999; 81 (4): 1506-12.
	Arachidonic acid potentiates currents through Ca2+-permeable AMPA receptors by interacting with a CaMKII pathway., Nishizaki T, Matsuoka T, Nomura T, Enikolopov G, Sumikawa K., Brain Res Mol Brain Res. April 6, 1999; 67 (1): 184-9.
	Investigation by ion channel domain transplantation of rat glutamate receptor subunits, orphan receptors and a putative NMDA receptor subunit., Villmann C, Strutz N, Morth T, Hollmann M., Eur J Neurosci. May 1, 1999; 11 (5): 1765-78.
	Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP., Akinshola BE, Taylor RE, Ogunseitan AB, Onaivi ES., Naunyn Schmiedebergs Arch Pharmacol. September 1, 1999; 360 (3): 242-8.
	Resolution, absolute stereochemistry and molecular pharmacology of the enantiomers of ATPA., Stensbøl TB, Borre L, Johansen TN, Egebjerg J, Madsen U, Ebert B, Krogsgaard-Larsen P., Eur J Pharmacol. September 10, 1999; 380 (2-3): 153-62.
	Potentiating effects of 4-[2-(phenylsulfonylamino)ethylthio]-2,6-difluoro-phenoxyaceta mide (PEPA) on excitatory synaptic transmission in dentate granule cells., Nakagawa T, Iino M, Sekiguchi M, Wada K, Ozawa S., Neurosci Res. December 1, 1999; 35 (3): 217-23.
	A desensitization-inhibiting mutation in the glutamate binding site of rat alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunits is dominant in heteromultimeric complexes., Thalhammer A, Morth T, Strutz N, Hollmann M., Neurosci Lett. December 31, 1999; 277 (3): 161-4.
	The contributions of GluR2 to allosteric modulation of AMPA receptors., Cotton JL, Partin KM., Neuropharmacology. January 1, 2000; 39 (1): 21-31.
	In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus., White HS, McCabe RT, Armstrong H, Donevan SD, Cruz LJ, Abogadie FC, Torres J, Rivier JE, Paarmann I, Hollmann M, Olivera BM., J Pharmacol Exp Ther. January 1, 2000; 292 (1): 425-32.
	Nefiracetam facilitates hippocampal neurotransmission by a mechanism independent of the piracetam and aniracetam action., Nomura T, Nishizaki T., Dev Biol. July 7, 2000; 870 (1-2): 157-62.
	Probing the topology of the glutamate receptor GluR1 subunit using epitope-Tag insertions., Anand R., Biochem Biophys Res Commun. September 16, 2000; 276 (1): 157-61.
	Assembly and ligand binding properties of the water-soluble extracellular domains of the glutamate receptor 1 subunit., Wells GB, Lin L, Jeanclos EM, Anand R., J Biol Chem. February 2, 2001; 276 (5): 3031-6.
	An N-methyl-D-aspartate receptor channel blocker with neuroprotective activity., Tai KK, Blondelle SE, Ostresh JM, Houghten RA, Montal M., Proc Natl Acad Sci U S A. March 13, 2001; 98 (6): 3519-24.
	Identification of amino acid residues in GluR1 responsible for ligand binding and desensitization., Banke TG, Greenwood JR, Christensen JK, Liljefors T, Traynelis SF, Schousboe A, Pickering DS., J Neurosci. May 1, 2001; 21 (9): 3052-62.
	Straight-chain alcohols exhibit a cutoff in potency for the inhibition of recombinant glutamate receptor subunits., Akinshola BE., Br J Pharmacol. July 1, 2001; 133 (5): 651-8.
	Involvement of non-NMDA receptors in the rescue of weaver cerebellar granule neurons and sensitivity to ethanol of cerebellar AMPA receptors in oocytes., Akinshola BE, Stewart RR, Karvonen LL, Taylor RE, Liesi P., Brain Res Mol Brain Res. September 10, 2001; 93 (1): 8-17.
	Does acetaldehyde mediate ethanol action in the central nervous system?, Mascia MP, Maiya R, Borghese CM, Lobo IA, Hara K, Yamakura T, Gong DH, Beckstead MJ., Alcohol Clin Exp Res. November 1, 2001; 25 (11): 1570-5.
	The aniracetam metabolite 2-pyrrolidinone induces a long-term enhancement in AMPA receptor responses via a CaMKII pathway., Nishizaki T, Matsumura T., Brain Res Mol Brain Res. January 31, 2002; 98 (1-2): 130-4.
	A desensitization-selective potentiator of AMPA-type glutamate receptors., Sekiguchi M, Nishikawa K, Aoki S, Wada K., Br J Pharmacol. August 1, 2002; 136 (7): 1033-41.
	The AMPA receptor subunit GluR1 regulates dendritic architecture of motor neurons., Inglis FM, Crockett R, Korada S, Abraham WC, Hollmann M, Kalb RG., J Neurosci. September 15, 2002; 22 (18): 8042-51.
	Solid-phase synthesis of polyamine toxin analogues: potent and selective antagonists of Ca2+-permeable AMPA receptors., Kromann H, Krikstolaityte S, Andersen AJ, Andersen K, Krogsgaard-Larsen P, Jaroszewski JW, Egebjerg J, Strømgaard K., J Med Chem. December 19, 2002; 45 (26): 5745-54.
	The selective activation of the glutamate receptor GluR5 by ATPA is controlled by serine 741., Nielsen MM, Liljefors T, Krogsgaard-Larsen P, Egebjerg J., Mol Pharmacol. January 1, 2003; 63 (1): 19-25.
	Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO)., Bjerrum EJ, Kristensen AS, Pickering DS, Greenwood JR, Nielsen B, Liljefors T, Schousboe A, Bräuner-Osborne H, Madsen U., J Med Chem. May 22, 2003; 46 (11): 2246-9.
	Glutamate receptor subunit 3 is modified by site-specific limited proteolysis including cleavage by gamma-secretase., Meyer EL, Strutz N, Gahring LC, Rogers SW., J Biol Chem. June 27, 2003; 278 (26): 23786-96.
	Identification of a site in GluR1 and GluR2 that is important for modulation of deactivation and desensitization., Leever JD, Clark S, Weeks AM, Partin KM., Mol Pharmacol. July 1, 2003; 64 (1): 5-10.
	Functional analysis of Caenorhabditis elegans glutamate receptor subunits by domain transplantation., Strutz-Seebohm N, Werner M, Madsen DM, Seebohm G, Zheng Y, Walker CS, Maricq AV, Hollmann M., J Biol Chem. November 7, 2003; 278 (45): 44691-701.
	Ethanol sensitivity of recombinant homomeric and heteromeric AMPA receptor subunits expressed in Xenopus oocytes., Akinshola BE, Yasuda RP, Peoples RW, Taylor RE., Alcohol Clin Exp Res. December 1, 2003; 27 (12): 1876-83.
	Determinants of the sensitivity of AMPA receptors to xenon., Plested AJ, Wildman SS, Lieb WR, Franks NP., Anesthesiology. February 1, 2004; 100 (2): 347-58.
	Anthraquinone polyamines: novel channel blockers to study N-methyl-D-aspartate receptors., Kashiwagi K, Tanaka I, Tamura M, Sugiyama H, Okawara T, Otsuka M, Sabado TN, Williams K, Igarashi K., J Pharmacol Exp Ther. June 1, 2004; 309 (3): 884-93.
	Molecular constituents of neuronal AMPA receptors., Fukata Y, Tzingounis AV, Trinidad JC, Fukata M, Burlingame AL, Nicoll RA, Bredt DS., J Cell Biol. May 9, 2005; 169 (3): 399-404.
	Regulation of GluR1 abundance in murine hippocampal neurones by serum- and glucocorticoid-inducible kinase 3., Strutz-Seebohm N, Seebohm G, Mack AF, Wagner HJ, Just L, Skutella T, Lang UE, Henke G, Striegel M, Hollmann M, Rouach N, Nicoll RA, McCormick JA, Wang J, Pearce D, Lang F., J Physiol. June 1, 2005; 565 (Pt 2): 381-90.
	Design of antagonists for NMDA and AMPA receptors., Bolshakov KV, Kim KH, Potapjeva NN, Gmiro VE, Tikhonov DB, Usherwood PN, Mellor IR, Magazanik LG., Neuropharmacology. August 1, 2005; 49 (2): 144-55.
	Tetrazolyl isoxazole amino acids as ionotropic glutamate receptor antagonists: synthesis, modelling and molecular pharmacology., Frølund B, Greenwood JR, Holm MM, Egebjerg J, Madsen U, Nielsen B, Bräuner-Osborne H, Stensbøl TB, Krogsgaard-Larsen P., Bioorg Med Chem. September 15, 2005; 13 (18): 5391-8.
	Functional characterisation of homomeric ionotropic glutamate receptors GluR1-GluR6 in a fluorescence-based high throughput screening assay., Strange M, Bräuner-Osborne H, Jensen AA., Comb Chem High Throughput Screen. February 1, 2006; 9 (2): 147-58.
	RNA interference of Xenopus NMDAR NR1 in vitro and in vivo., Miskevich F, Doench JG, Townsend MT, Sharp PA, Constantine-Paton M., J Neurosci Methods. April 15, 2006; 152 (1-2): 65-73.
	Additive regulation of GluR1 by stargazin and serum- and glucocorticoid-inducible kinase isoform SGK3., Strutz-Seebohm N, Seebohm G, Korniychuk G, Baltaev R, Ureche O, Striegel M, Lang F., Pflugers Arch. June 1, 2006; 452 (3): 276-82.
	Bi-directional control of motor neuron dendrite remodeling by the calcium permeability of AMPA receptors., Jeong GB, Werner M, Gazula VR, Itoh T, Roberts M, David S, Pfister B, Cohen A, Neve RL, Hollmann M, Kalb R., Mol Cell Neurosci. July 1, 2006; 32 (3): 299-314.
	3-hydroxypyridazine 1-oxides as carboxylate bioisosteres: a new series of subtype-selective AMPA receptor agonists., Greenwood JR, Mewett KN, Allan RD, Martín BO, Pickering DS., Neuropharmacology. July 1, 2006; 51 (1): 52-9.
	AMPA receptors regulate experience-dependent dendritic arbor growth in vivo., Haas K, Li J, Cline HT., Proc Natl Acad Sci U S A. August 8, 2006; 103 (32): 12127-31.
	Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor., Masuko T, Nagaoka H, Miyake M, Metori K, Kizawa Y, Kashiwagi K, Igarashi K, Kusama T., Neurochem Int. January 1, 2007; 50 (2): 443-9.
	Electrophysiological properties of AMPA receptors are differentially modulated depending on the associated member of the TARP family., Kott S, Werner M, Körber C, Hollmann M., J Neurosci. April 4, 2007; 27 (14): 3780-9.
	A tetrazolyl-substituted subtype-selective AMPA receptor agonist., Vogensen SB, Frydenvang K, Greenwood JR, Postorino G, Nielsen B, Pickering DS, Ebert B, Bølcho U, Egebjerg J, Gajhede M, Kastrup JS, Johansen TN, Clausen RP, Krogsgaard-Larsen P., J Med Chem. May 17, 2007; 50 (10): 2408-14.
	Stargazin interaction with alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors is critically dependent on the amino acid at the narrow constriction of the ion channel., Körber C, Werner M, Hoffmann J, Sager C, Tietze M, Schmid SM, Kott S, Hollmann M., J Biol Chem. June 29, 2007; 282 (26): 18758-66.
	Functional characterization of Tet-AMPA [tetrazolyl-2-amino-3-(3-hydroxy-5-methyl- 4-isoxazolyl)propionic acid] analogues at ionotropic glutamate receptors GluR1-GluR4. The molecular basis for the functional selectivity profile of 2-Bn-Tet-AMPA., Jensen AA, Christesen T, Bølcho U, Greenwood JR, Postorino G, Vogensen SB, Johansen TN, Egebjerg J, Bräuner-Osborne H, Clausen RP., J Med Chem. August 23, 2007; 50 (17): 4177-85.
	A domain linking the AMPA receptor agonist binding site to the ion pore controls gating and causes lurcher properties when mutated., Schmid SM, Körber C, Herrmann S, Werner M, Hollmann M., J Neurosci. November 7, 2007; 27 (45): 12230-41.
	Stargazin modulates AMPA receptor antagonism., Cokić B, Stein V., Neuropharmacology. June 1, 2008; 54 (7): 1062-70.
	Disruption of agonist and ligand activity in an AMPA glutamate receptor splice-variable domain deletion mutant., Johnson WD, Parandaman V, Onaivi ES, Taylor RE, Akinshola BE., Dev Biol. July 30, 2008; 1222 18-30.
	Role of GluR1 in activity-dependent motor system development., Zhang L, Schessl J, Werner M, Bonnemann C, Xiong G, Mojsilovic-Petrovic J, Zhou W, Cohen A, Seeburg P, Misawa H, Jayaram A, Personius K, Hollmann M, Sprengel R, Kalb R., J Neurosci. October 1, 2008; 28 (40): 9953-68.
	Arabidopsis thaliana glutamate receptor ion channel function demonstrated by ion pore transplantation., Tapken D, Hollmann M., J Mol Biol. October 31, 2008; 383 (1): 36-48.
	Comparative analysis of the pharmacology of GluR1 in complex with transmembrane AMPA receptor regulatory proteins gamma2, gamma3, gamma4, and gamma8., Kott S, Sager C, Tapken D, Werner M, Hollmann M., Neuroscience. January 12, 2009; 158 (1): 78-88.

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 ???pagination.result.next???